RecruitingNCT06560983

One Year Mortality and Morbidity With Hyperglycemia Among Acute Cerebrovascular Accident Patients in Emergency Department: A Cohort Study

One Year Mortality and Morbidity Outcome With Hyperglycemia Among Acute Cerebrovascular Accident Patients in Emergency Department: A Prospective Cohort Study


Sponsor

Institute of medicine, Maharagjung medical campus

Enrollment

46 participants

Start Date

Jan 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The "One Year Mortality and Morbidity Outcome with Hyperglycemia among Acute Cerebrovascular Accident Patients in Emergency Department" is an extensive prospective cohort study designed to look into how hyperglycemia affects the short- and long-term outcomes of patients who present to the emergency room with acute cerebrovascular accidents (CVAs). Worldwide, cerebrovascular accidents are a major source of both death and morbidity. Research on the long-term consequences of hyperglycemia and its association with worse outcomes during the acute period of stroke is still underway. This study aims to close this information gap by investigating the relationship between the rates of immediate short- and one-year mortality rates and morbidity and hyperglycemia at the time of CVA presentation. The research design adopts a prospective cohort approach, aligning with established guidelines to ensure methodological rigor. Systematic random sampling will be employed, with a calculated sample size of 60. Patients with acute cerebrovascular accidents who are admitted to the emergency department will be a carefully chosen group for the research. The investigators will carefully gather important data, such as baseline clinical parameters, medical history, demographics, and blood glucose levels upon admission. Throughout a year, follow-up evaluations will be carried out regularly to monitor death rates and evaluate functional and neurological results in research participants using the modified Rankin score. The study will use a structured questionnaire for data collection, involving chart review and face-to-face interviews at specified intervals. Data analysis will include bivariate analysis, logistic regression, and Kaplan-Meier analysis to identify predictors of mortality and morbidity. The ultimate goal of this research is to improve patient care, prognosis, and long-term quality of life for those impacted by this critical medical condition by illuminating the prolonged effects of hyperglycemia in acute cerebrovascular accident patients and deepening our understanding of the intricate interactions between metabolic factors and stroke outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Individuals exhibiting BEFAST-positive symptoms - meeting at least one of the criteria within 24 hours of symptom onset.
  • Confirmation of acute stroke through CT imaging.
  • Participants aged over 40 years.

Exclusion Criteria10

  • Patients presenting with hypoglycemia
  • Transient Ischemic Attack (TIA).
  • Subdural hematoma cases.
  • Subarachnoid hemorrhage cases.
  • Diabetic Ketoacidosis.
  • Conditions mimicking stroke symptoms (e.g., sepsis, metabolic derangement, space-occupying lesions, hepatic encephalopathy).
  • History of bedridden patients.
  • Acute-on-chronic stroke cases.
  • Patients requiring assistance in daily activities.
  • History of trauma preceding the stroke.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERThe investigators are planning to do a observational cohort study, hence won't be doing any intervention.

The investigators won't be doing any intervention since this is an observational study.


Locations(2)

Bibek Rajbhandari

Kathmandu, Bagmati, Nepal

Bibek Rajbhandari

Kathmandu, Bagmati, Nepal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06560983


Related Trials